Circulating leukocyte telomere length and oxidative stress: A new target for statin therapy

2011 ◽  
Vol 219 (2) ◽  
pp. 753-760 ◽  
Author(s):  
Sebastien Saliques ◽  
Jean-Raymond Teyssier ◽  
Catherine Vergely ◽  
Luc Lorgis ◽  
Julie Lorin ◽  
...  
PLoS ONE ◽  
2011 ◽  
Vol 6 (3) ◽  
pp. e17837 ◽  
Author(s):  
Owen M. Wolkowitz ◽  
Synthia H. Mellon ◽  
Elissa S. Epel ◽  
Jue Lin ◽  
Firdaus S. Dhabhar ◽  
...  

2020 ◽  
Author(s):  
Katia Martínez‐González ◽  
Azul Islas‐Hernández ◽  
José Darío Martínez‐Ezquerro ◽  
Federico Bermúdez‐Rattoni ◽  
Paola Garcia‐delaTorre

2019 ◽  
Author(s):  
Katia Martínez-González ◽  
Azul Islas-Hernández ◽  
José Darío Martínez-Ezquerro ◽  
Federico Bermúdez-Rattoni ◽  
Paola Garcia-delaTorre

AbstractAlzheimer’s Disease (AD) is the most common cause of dementia and aging is its major risk factor. Changes in telomere length have been associated with aging and some degenerative diseases. Our aim was to explore some of the molecular changes caused by the progression of AD in a transgenic murine model (3xTg-AD; B6; 129-Psen1 <tm1Mpm> Tg (APPSwe, tauP301L) 1Lfa). Telomere length was assessed by qPCR in both brain tissue and peripheral blood cells and compared between three age groups: 5, 9, and 13 months. In addition, a possible effect of oxidative stress on telomere length and AD progression was explored. Shorter telomeres were found in blood cells of older transgenic mice compared to younger and wild type mice but no changes in telomere length in the hippocampus. An increase in oxidative stress with age was found for all strains but no correlation was found between oxidative stress and shorter telomere length for transgenic mice. Telomere length and oxidative stress are affected by AD progression in the 3xTg-AD murine model. Changes in blood cells are more noticeable than changes in brain tissue, suggesting that systemic changes can be detected early in the disease in this murine model.


Sign in / Sign up

Export Citation Format

Share Document